Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
News
Back to overview
Nikkei Bio Article: Perseus Proteomics, development of an anti-TfR antibody for ANKL submitted for regulatory approval with results from phase 1/2 trial
Nikkei Bio article in JP:
https://bio.nikkeibp.co.jp/atc...